Novartis: CHMP Recommends Afinitor For EU Approval In Advanced ... RTT News ... European Medicines Agency has recommended Afinitor (everolimus) tablets, in combination with exemestane, for the treatment of advanced breast cancer. Novartis: EU Backs Afinitor in Breast Cancer |
